Microglial ion channels: Key players in non-cell autonomous neurodegeneration

Souvarish Sarkar1

  • 1Dept. of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Neurobiology of Disease
|September 17, 2022
PubMed

Insights

Microglia, the brain's immune cells, drive neuroinflammation in disorders like Alzheimer's and Parkinson's. This review explores how microglial ion channels regulate these cells and their potential as therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Neuroinflammation is a key feature of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD).
  • Microglia, the brain's resident immune cells, are central to neuroinflammation, releasing pro-inflammatory factors that contribute to neurodegeneration.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) show potential in reducing PD risk, but the precise mechanisms of microglial activation remain under investigation.

Conclusions:

  • Microglial ion channels are vital regulators of microglial function and neuroinflammation.
  • Targeting specific microglial ion channels presents a promising avenue for novel therapeutic interventions in neurodegenerative diseases.
  • Further research into microglial ion channel signaling is essential for developing effective treatments.